Carderock Capital Management’s Insmed INSM Stock Holding History

Carderock Capital Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2	Closed	–	–	145
2014 Q1	$0	Buy	+2	New	+$38	﹤0.01%	252

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carderock Capital Management's INSM Position: Q2 2014 in Review

Carderock Capital Management sold out of Insmed (INSM) in Q2 2014, closing a stake of 2 shares.

Carderock Capital Management first reported a position in INSM in Q1 2014 and held it in 1 quarter. The position peaked at $0 in Q1 2014. 103 funds tracked by Wall St. Rank hold INSM as of Q2 2014.

Carderock Capital Management reported no remaining Insmed position as of Q2 2014 after selling out during the quarter.
Carderock Capital Management sold 2 Insmed shares in Q2 2014.
Carderock Capital Management first reported a position in Insmed in Q1 2014 and held it in 1 quarter.
Carderock Capital Management's Insmed position peaked at $0 in Q1 2014.
103 funds tracked by Wall St. Rank held Insmed as of Q2 2014.

Based on Carderock Capital Management's 13F filing for Q2 2014, filed 6 Aug 2014.